analiza aiqbench

This article covers NetraMark's NetraAI, an explainable AI system that searches clinical trial data for patient subgroups that respond differently to a treatment. The pitch is plausible, but the piece gives no validation results, trial outcomes, or peer review, so the claims about reshaping trials remain unproven. Readers should watch for published evidence that subgroup findings hold up prospectively.